Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited is an Indian listed company in the Chemicals & Petrochemicals industry (Commodities sector), traded under NSE: TATVA and BSE: 543321 (ISIN INE0GK401011).
It has a market capitalisation of ₹4,452 crore, a last close of ₹1,903 on 2026-10-19, a one-year return of 43.2%.
Valuation: a price-to-earnings ratio of 70.77x, a price-to-book ratio of 5.70x, a dividend yield of 0.1%.
Profitability: return on equity of 5.5%, return on capital employed of 7.8%, an operating margin of 19.5%.
Growth: sales growth of 6.1% a year over three years, net profit growth of -2.6% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.15x, promoter holding of 72.0%.
| Metric | Value |
|---|---|
| Market capitalisation | 4,452 |
| Last close | ₹1,903 |
| P/E (TTM) | 70.77x |
| P/B | 5.70x |
| Dividend yield | 0.1% |
| ROE (FY) | 5.5% |
| ROCE (FY) | 7.8% |
| Operating margin (TTM) | 19.5% |
| Sales growth, 3-year CAGR | 6.1% |
| Profit growth, 3-year CAGR | -2.6% |
| Debt / equity | 0.15x |
| Promoter holding | 72.0% |
| 1-year return | 43.2% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means